viewLexaria Bioscience Corp.

Lexaria Bioscience, Hill Street Beverage sign 10-year joint manufacturing partnership for DehydraTech products

Under the partnership, both Canadian companies will jointly produce Lexaria's DehydraTech products, including THC and CBD powder

DehydraTECH masks the flavor and increases effectiveness of CBD in beverages

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) and Hill Street Beverage Company Inc (CVE:BEER) announced Wednesday that they have entered into a joint manufacturing partnership to produce DehydraTech products, including THC and CBD powder.

Under the partnership, which is valid for 10 years, the powder will be used to produce consumer products like tablets, capsules, or packets for sale in Canada and for export where permitted. Also, the powder will be sold in bulk to licensed producers.

Manufacturing will be done at Hill Street's soon-to-be-acquired OneLeaf Cannabis cultivation and processing facility in Regina, Saskatchewan, pending licensing by Health Canada.

Hill Street will own and manage all aspects of the manufacturing business under Lexaria's own license and patents for DehydraTECH and its related processes. Profits from this business unit will be shared equally between Hill Street and Lexaria, based in Kelowna, British Columbia.

READ: Lexaria Bioscience is seeing increased demand for its DehydraTECH drug delivery system

A novel drug-delivery platform, Lexaria created DehydraTECH to mask unwanted tastes, improve onset speed and increases the bioavailability of active pharmaceutical ingredients in a simple and cost-effective platform.

It allows drugs and vitamins – in the case of cannabis, CBD and THC – to enter the bloodstream faster than existing drug delivery platforms.

The partnership will, for the first time ever, permit intermediate ingredients made from cannabis processed by Lexaria's DehydraTECH to be legally sold within Canada on a business-to-business basis between licensed producers and others licensed by Health Canada to manufacture cannabis-infused edibles, including both THC and CBD.

READ: Hill Street makes big bet on cannabis-infused drinks

Hill Street, which is gearing up to produce its own line of cannabis-infused beverages, has acquired two global semi-exclusive licenses to utilize the DehydraTECH THC beverage infusion technology, and to use the DehydraTECH CBD infusion technology around the world for 10 years. This expands a 2018 license award to Hill Street to use DehydraTECH for THC beverages in Canada only,

Under the terms of the agreement, Toronto-based Hill Street will pay up to US$1,800,000 to Lexaria by issuing US$800,000 in common shares to the company at the lower market price on the day prior to the announcement of the agreement, or C$0.23 per share. Lexaria will issue US$250,000 in restricted common shares to Hill Street.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Quick facts: Lexaria Bioscience Corp.

Price: 0.25 CAD

Market: CSE
Market Cap: $22.51 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp. named herein, including the promotion by the Company of Lexaria Bioscience Corp. in any Content on the Site, the...


Lexaria receives ethics board ok to launch human study with DehydraTech for...

Lexaria Bioscience (CSE: LXX-OTCQX: LXRP) CEO Chris Bunka joined Steve Darling from Proactive with news the company has received ethics board approval to conduct a pilot human pharmacokinetic exploratory study of antiviral drugs that have previously been studied against other coronavirus...

3 weeks, 5 days ago

2 min read